Sigmaringendorf, Germany

Andreas Koeberle



 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Andreas Koeberle: A Journey into Pharmaceutical Chemistry

Introduction: Andreas Koeberle, a prominent inventor located in Sigmaringendorf, DE, is known for his contributions to pharmaceutical chemistry. With a remarkable patent to his name, his work focuses on tocotrienol derivatives and their applications in treating 5-lipoxygenase related diseases. This article highlights his latest patent, career highlights, and significant collaborations.

Latest Patents: Andreas Koeberle holds a patent titled "Tocotrienol derivatives, pharmaceutical composition and method of use in 5-lipoxygenase related diseases." This invention relates to compounds of specific formulas that could provide therapeutic benefits in addressing certain medical conditions linked to 5-lipoxygenase pathways.

Career Highlights: Throughout his career, Andreas has been associated with esteemed institutions such as Université D'Angers and Universität Innsbruck. His work at these universities has contributed to advancing research in the field of pharmaceutical sciences and the development of new medicinal compounds.

Collaborations: During his research journey, Andreas has collaborated with notable coworkers, including Pascal Richomme and Jean-Jacques Helesbeux. Their combined expertise has significantly contributed to the progress and validation of his innovative research.

Conclusion: Andreas Koeberle’s inventive spirit and dedication to pharmaceutical innovation make him a noteworthy figure in the sciences. His patented work on tocotrienol derivatives not only reflects his expertise but also holds promise for future applications in treating diseases related to 5-lipoxygenase. As research continues to evolve, the impact of his inventions will likely extend further into the realm of pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…